Know Labs (NYSEAMERICAN:KNW) Coverage Initiated by Analysts at Benchmark

Benchmark initiated coverage on shares of Know Labs (NYSEAMERICAN:KNW) in a research note released on Monday, Benzinga reports. The brokerage issued a speculative buy rating and a $1.00 target price on the stock.

Know Labs Price Performance

Shares of KNW stock opened at $0.64 on Monday. Know Labs has a 12-month low of $0.23 and a 12-month high of $1.48. The stock has a market cap of $52.06 million, a P/E ratio of -1.73 and a beta of 1.63.

Know Labs (NYSEAMERICAN:KNW) last announced its earnings results on Wednesday, February 14th. The company reported ($0.04) earnings per share for the quarter. On average, equities research analysts expect that Know Labs will post -0.08 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Northern Trust Corp lifted its position in shares of Know Labs by 27.7% in the fourth quarter. Northern Trust Corp now owns 100,710 shares of the company’s stock worth $51,000 after purchasing an additional 21,823 shares in the last quarter. Citadel Advisors LLC bought a new stake in Know Labs during the fourth quarter worth $77,000. Geode Capital Management LLC raised its position in Know Labs by 957.6% during the second quarter. Geode Capital Management LLC now owns 154,033 shares of the company’s stock worth $156,000 after acquiring an additional 139,469 shares in the last quarter. Callan Capital LLC raised its position in Know Labs by 117.6% during the fourth quarter. Callan Capital LLC now owns 370,000 shares of the company’s stock worth $188,000 after acquiring an additional 200,000 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in Know Labs by 112.3% during the third quarter. Vanguard Group Inc. now owns 481,983 shares of the company’s stock worth $120,000 after acquiring an additional 254,972 shares in the last quarter. Institutional investors and hedge funds own 23.96% of the company’s stock.

Know Labs Company Profile

Know Labs, Inc, together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.